news.mslog.com

Prozac Limits Lesions

admin — Sat, 03 May 2008 15:50:27 +0000

A small double blind study of Prozac therapy for multiple sclerosis has concluded with a reduction of neurological inflammation for the group recieving the active medication. The results suggest further study.

A Pill a Day - Keeps the Attacks Away

admin — Wed, 16 Apr 2008 20:58:08 +0000

Studies have shown that the Novartis compound called FT720 has shown a high effectiveness for stopping exacerbations for up to 75 % of multiple sclerosis patients after three years in an extended clinical trial. The medicine is a once a day pill that would be a more palatable alternative to the injectable therapies that are commonplace for treating MS presently.

Rituxin Disappoints

admin — Tue, 15 Apr 2008 20:44:36 +0000

There were hopes that the drug Rituxin might benefit multiple sclerosis patients with the primary progressive stage of the disease, but a long term study of the therapy failed to produce a significant benefit.

Your Opionion Matters

admin — Sat, 12 Apr 2008 21:58:22 +0000

The firm devoloping brochures and informational materials for a multiple sclerosis clinical trial wants your thoughts on design and suggestions on content. If you are interested please visit the post in the forum by clicking here.

T- Cell Booster

admin — Tue, 25 Mar 2008 12:17:13 +0000

A new drug that has been proven effective against auto immune disease in mice is now being studied in humans with multiple sclerosis to determine if the same positive results can be achieved.

Testing Heat Sensitivity

admin — Fri, 21 Mar 2008 14:21:23 +0000

UT Southwestern scientists are using a special suit that delivers heating or coooling to MS patients and then observing the resulting effects on vision, The results may help develop and determine therapies for heat related symptoms in multiple sclerosis.

Worm Egg Therapy

admin — Sun, 09 Mar 2008 16:21:20 +0000

A small study to determine whether the hatching of worm eggs within human patients with multiple sclerosis is slated to begin. The hope is the invasion of worms will provoke a positive immune response that will have the effect of reducing multiple sclerosis activity for those patients.

Tysabri Adds Liver Injury Watch

admin — Wed, 27 Feb 2008 22:05:33 +0000

In an FDA reported letter Biogen and Elan issued concerns about the development of significant liver damage as a result of beginning Tysabri therapy.

Cancer Caution Urged

admin — Thu, 07 Feb 2008 19:19:27 +0000

Patients and doctors are being encouraged to excercise caution before treating multiple sclerosis with newcomer Tysabri. If there is is a family history of melanoma or the presence of atypical moles there may be an increased possibility of developing skin cancer.

Adhesion Molecules : A New Target

admin — Thu, 24 Jan 2008 21:22:33 +0000

By targeting specially identified brain molecules an international research team hope to provide a therapy that will lessen the inflammation and decrease lesions in multiple sclerosis patients.